课题基金 / 基金详情

Helping people adhere to their varenicline treatment by co-creating a conversational agent: A feasibility study

Helping people adhere to their varenicline treatment by co-creating a conversational agent: A feasibility study
通过共同创建对话代理来帮助人们坚持伐尼克兰治疗：可行性研究
批准号：
460545
负责人：
Minian Nadia
金额：
$9.11万
依托单位：
Centre for Addiction and Mental Health (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-09-01 至 2022-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=460545&lang=en
关键词：
Cancer

项目摘要

项目成果

Minian Nadia的其他基金

相似基金

相关文献

中文摘要
翻译
需要把项目所需 伐尼克兰是最有效的戒烟药物，但大多数人不服用 按照指示。教育和促进问题解决可以提高依从性，但实施 这些干预是昂贵的。该项目将
英文摘要
Need for project Varenicline is the most effective smoking cessation medication, but most people do not take it as directed. Education and facilitating problem solving improves adherence, but implementing these interventions are costly. This project will
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Co-creating digital solutions for problem drinking in treatment-seeking smokers to reduce (compounded) risk for cancer.
Helping people adhere to their varenicline treatment by co-creating a conversational agent: A feasibility study
海外基金